A scientist at a well known university has been working for several years on the development of a drug that is a treatment for a special type of cancer. He has successfully completed all pre-clinical trials and has filed an application for an investigational new drug.
When the Food and Drug Administration approves this application, then the scientist would intend to embark on a series of clinical trials. Although research grants and personal funds have financed his work to this stage, he must obtain more substantial financing from a venture capitalist. However, the scientist doesn't know what his fledgling business could be worth.
Publication Date: 11/29/2002
This is just an excerpt. This case is about Finance
Related Case Solutions & Analyses:
Advanced Micro Devices: Competing in the Shadow of a Giant (A)
Enterprise Risk Management at Hydro One (A)
Law and Legal Reasoning: An Introduction
John Preston
The Case of the Unidentified Industries – 2013, Chinese Version
A Simple Free Cash Flow Valuation Model
Contempo Technologies, Inc. and Betty Sievers: A Clash of Interests in an Uncertain Time
Belco Global Foods
Annotated bibliography
Introduction to Interest Rate Options
